| 标题 |
Defining the antitumor mechanism of action of a clinical-stage compound as a selective degrader of the nuclear pore complex 确定作为核孔复合物选择性降解剂的临床阶段化合物的抗肿瘤作用机制
|
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Discovery 作者:Linjie Yuan; Wenzhi Ji; Brendan G. Dwyer; Joey Lu; Jing Bian; et al 出版日期:2025 |
| 求助人 | |
| 下载 |